Global Non-Invasive Prenatal Testing (NIPT) Market 2020-2031: Focus on Method, Test, Platform, End User, Application and Country –

DUBLIN–(BUSINESS WIRE)–The “Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Test, Platform, End User, Application and Country Analysis and Forecast, 2020-2031” report has been added to from offer.

Global NIPT Market was valued at USD 2.52 Billion in 2020 and is projected to reach USD 12.61 Billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.

Market dynamics

  • Growth engines

    • Increased focus on early detection and prevention

    • Availability of advanced screening technologies

    • Increase in consumer demand

    • Reorientation of reimbursement policies towards greater genetic coverage

    • High incidence rate of Down syndrome

    • Increase in the average age of the mother

    • Increased prevalence of genetic and congenital disorders

  • Challenges

    • Strict regulatory guidelines and ethical hurdles

    • Limits of NIPT

    • Lack of consumer awareness

    • Alternative Screening and Testing Methods

  • Opportunities

    • Capitalize on the potential presented by emerging markets in Asia

    • Availability of direct-to-consumer testing

    • Focus on pre-implantation genetic diagnosis

Market segmentation

  • By test – Panorama and Vistara; MaterniT GENOME, MaterniT 21 PLUS, informaSeq, Verifi and Verifi Plus prenatal tests; harmony test; NIFTY Test and NIFTY Test Pro; QNatal Advanced; PrenaTest, GeneSafe and PrenatalSAFE; Bambni test; IONA and Sage; and others

  • By platform – PCR, next-generation sequencing and others

  • By method – cfDNA and FCMB

  • By End User – Hospitals, Clinics, Diagnostic Laboratories and Others

  • By Application – Trisomy Detection, Microdeletion Detection, Sex Chromosome Aneuploidy Detection, Others

Competitive landscape

The NIPT market is currently in a flowering stage, with the presence of various behemoths such as Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Illumina, Inc., Agilent Technologies, Inc., BGI, and PerkinElmer Inc., as well than other medium and small medium enterprises, which offer a wide range of NIPT products and services in the market. Several companies are trying to enter the market and stay competitive by adopting different strategies ranging from partnerships and collaborations to business expansions and product launches.

Profiled companies

  • Agilent Technologies, Inc.

  • F. Hoffmann-La Roche Ltd.

  • PerkinElmer, Inc.

  • Quest Diagnostics Incorporated

  • Illumina, Inc.

  • Myriad Genetics, Inc.

  • BGI


  • Laboratory Corporation of America Holdings

  • MedGenome Inc.

  • Annoroad Gene Technology

  • Natera, Inc.

  • Yourgene Health PLC

  • Next Biosciences

  • Eurofins Scientific

Key Questions Answered by the Report

  • What is the importance of NIPT and what are the different NIPT products/services available in the market? What are the different methods of NIPT, and what are the benefits and risks associated with them?

  • What are the key technological advancements seen in the global NIPT market in the past four years and what is the future scope of the market? What are the key trends for the global NIPT market in 2020 and how is the market currently developing?

  • What was the global NIPT market size in 2020 and what is the forecast market size in 2031? What is the expected growth rate of the global NIPT market during the period 2021-2031?

  • What is the market scenario and growth potential of different regions around the world, including North America, Europe, Asia-Pacific, and Rest of the World?

  • What are the key drivers, challenges, and opportunities in the global NIPT market?

  • Who are the major key players in the global NIPT market? What market share does each of these players occupy in the market in 2019? Which companies are expected to be highly disruptive in the future, and why?

  • What is the regulatory scenario of the global NIPT market? What are the initiatives implemented by the various government bodies and the guidelines proposed to regulate the marketing of NIPT products?

  • What is the average cost of NIPT in different countries? What is the reimbursement scenario of Global NIPT Market and what is the reimbursement rate in different countries around the world including countries in North America, Latin America, Asia-Pacific, Europe, Middle -East and Africa?

  • What is the market funding scenario for institutional and academic funding? What is the market patent landscape and which companies stand out for filing the most patents?

  • What are the key development strategies implemented by the major players of the global NIPT market to sustain the market competition? What is the percentage share of each of the key players in the various key development strategies?

  • What are the different NIPT tests available in the market, and which type of test dominates the market in 2020 and 2031 in terms of value and volume?

  • What is the global market size (by value & volume) of the various product types of the Global NIPT Market in 2020? What are the key market trends with respect to different kits, tests and which product is expected to dominate the market in 2031?

  • What are the different platforms supported by NIPT products? What type of technology dominated the market in 2020 and is expected to dominate in 2031 (by value and volume)?

  • What are the different applications associated with NIPT? What was the contribution of each of the application areas in the global NIPT market for the period between 2021 and 2031 (in value and volume)?

  • What is the global NIPT market size (by value & volume) by different methods? Which method currently dominates the market and why? Which method is expected to lead the market during the forecast period?

  • Who are the various end users of the Global NIPT Market (by value & volume)? What type of end user is the main revenue contributor in the market?

For more information on this report, visit

Comments are closed.